Wockhardt charting a recovery riding on a promising new antibiotic

While global trials are on, doctors have started using one of company's antibiotics against superbugs to save lives

Image
Business Standard
1 min read Last Updated : Sep 08 2023 | 10:30 AM IST
Mumbai-headquartered Wockhardt is charting a turnaround plan, riding on its promising antibiotic pipeline, led by a candidate codenamed WCK5222.

Rarely, an undertrial novel drug developed in India is sought after by doctors to save patient lives. WCK5222 has already saved five patients here under a compassionate use programme.

Quarterly Starter

₹900

3 Months

₹300/Months

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Months

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories Online

  • Over 30 premium stories daily, handpicked by our editors for subscribers

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Wockhardt Biocon Manappuram Finance

Gold price in Delhi today is ₹ 84,470, Click Here for other cities. Silver price in Delhi today is ₹ 84,470, Click Here for other cities.

First Published: Sep 08 2023 | 10:30 AM IST

Next Story